CHM chimeric therapeutics limited

IMU - announced a couple Complete Respinses in their Phase 1b...

  1. 294 Posts.
    lightbulb Created with Sketch. 92
    IMU - announced a couple Complete Respinses in their Phase 1b trial of Azercel for b cell lymphoma. 100m+ shares traded on commsec, with a $0.004 increase in share price amounting to $30mill increase in market cap.

    so what will CHMs share price do if they release positive data on their CDH17 GI cancer treatment with a target market that is 5 times bigger and a current market cap of $10m?

    https://hotcopper.com.au/data/attachments/6811/6811917-6a21cb5b59625a6158e1506d1f840de4.jpg

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $432 98K

Buyers (Bids)

No. Vol. Price($)
26 22188206 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 25892021 31
View Market Depth
Last trade - 13.15pm 16/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.